Almost every human disease is driven by genetics. So what if we could cure every genetic disease, from Alzheimer's to cancer?
These may sound like lofty aspirations. But the team at Neubase Therapeutics has developed a method for temporarily modifying disease-causing genes without permanently altering the genome. The backbone of Neubase's technology is also highly adaptable. If successful, the company could only need to make small tweaks to develop a brand new therapy, avoiding years of difficult and expensive clinical trials.
Tune in to hear more about Neubase's cutting-edge approach and much more!
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces